title: Perceptions and prescribing considerations among US psychiatrists regarding drug-drug interactions associated with oral atypical antipsychotics.
authors.affiliation: Analysis Group, Inc, Boston, MA, USA. cfrois@analysisgroup.com
authors.forename: Christian
authors.initials: C
authors.lastname: Frois
authors.forename: Annie
authors.initials: A
authors.lastname: Guerin
authors.forename: Amit
authors.initials: A
authors.lastname: Saraogi
authors.forename: Jessica
authors.initials: J
authors.lastname: Panish
authors.forename: Riad
authors.initials: R
authors.lastname: Dirani
mesh_terms: D000284:Administration, Oral; D014150:Antipsychotic Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000494:pharmacology; D001364:Awareness / Q000502:physiology; D003625:Data Collection; D004347:Drug Interactions; D016903:Drug Monitoring / Q000706:statistics & numerical data; D064420:Drug-Related Side Effects and Adverse Reactions / Q000453:epidemiology / Q000209:etiology / Q000473:pathology; D007722:Health Knowledge, Attitudes, Practice; D006801:Humans; D057970:Inappropriate Prescribing / Q000523:psychology / Q000706:statistics & numerical data*; D015994:Incidence; D010465:Perception / Q000502:physiology; D011361:Professional Competence; D011570:Psychiatry; D012720:Severity of Illness Index; D014481:United States
chemical_list: D014150:Antipsychotic Agents